Contemporary alternatives to plant estrogens for menopause

Maturitas

Volumn 55, Issue SUPPL. 1, 2006, Pages

  Geller, Stacie E ^a   Studee, Laura ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Botanical supplements; Dietary supplements; Menopause

Indexed keywords

ACETYLSALICYLIC ACID; ANGELICA SINENSIS EXTRACT; ANTICOAGULANT AGENT; CHAMOMILE; CIMICIFUGA RACEMOSA EXTRACT; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYCLOSPORIN; DIAZEPAM; DIGOXIN; DIOSCOREA VILLOSA EXTRACT; ESTRADIOL; ESTRIOL; ESTROGEN; GESTAGEN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; LEONURUS CARDIACA EXTRACT; MEDROXYPROGESTERONE ACETATE; PLANT EXTRACT; PRIMROSE OIL; PROTEINASE INHIBITOR; RED CLOVER EXTRACT; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; VITEX AGNUS CASTUS EXTRACT;

ALTERNATIVE MEDICINE; AMNESIA; ANGELICA SINENSIS; ARTICLE; CIMICIFUGA RACEMOSA; CLIMACTERIUM; CLINICAL TRIAL; DATA BASE; DEPRESSION; DIET SUPPLEMENTATION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EVENING PRIMROSE; EVIDENCE BASED PRACTICE; GINKGO BILOBA; GINSENG; HEALTH CARE PERSONNEL; HUMAN; HYPERICUM PERFORATUM; LEONURUS; LIVER FAILURE; LIVER TOXICITY; MEDICAL LITERATURE; MEDLINE; MENOPAUSAL SYNDROME; MENOPAUSE; MOOD DISORDER; NAUSEA; NERVOUSNESS; NONHUMAN; PIPER METHYSTICUM; POSTMENOPAUSE; PREMENSTRUAL SYNDROME; SLEEP DISORDER; STOMACH DISEASE; VALERIANA OFFICINALIS; VASOMOTOR DISORDER; VASOMOTOR REFLEX; VITEX AGNUS CASTUS; VOMITING; YAM;

DEPRESSION; DIETARY SUPPLEMENTS; FEMALE; HOT FLASHES; HUMANS; MEMORY DISORDERS; MENOPAUSE; MOOD DISORDERS; PHYTOTHERAPY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

CIMICIFUGA DAHURICA;

EID: 33750615922     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.06.012     Document Type: Article

References (90)

1. World menopause day [website] (2005), International Menopause Society, Lancaster, England. http://www.imsociety.org/pages/wmday.html [accessed December 2, 2005], available from: http://www.imsociety.org/pages/wmday.html
2. Dennerstein L., and Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 11 (2004) 778-785
3. Singh A., Kaur S., and Walia I. A historical perspective on menopause and menopausal age. Bull Indian Inst Hist Med Hyderabad 32 (2002) 121-135
4. Rizk D.E., Bener A., Ezimokhai M., Hassan M.Y., and Micallef R. The age and symptomatology of natural menopause among United Arab Emirates women. Maturitas 29 (1998) 197-202
5. Chim H., Tan B.H., Ang C.C., Chew E.M., Chong Y.S., and Saw S.M. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 41 (2002) 275-282
6. Castelo-Branco C., Palacios S., Mostajo D., Tobar C., and von Helde S. Menopausal transition in Movima women, a Bolivian Native-American. Maturitas 51 (2005) 380-385
7. Avis N.E., Stellato R., Crawford S., et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52 (2001) 345-356
8. Kolata G. Race to fill the void in menopause drug market (2002), The New York Times, New York p. 1
9. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 (2002) 321-333
10. Botanicals and botanical preparations widely used as food supplements and related products: coherent and comprehensive risk assessment and consumer information approaches [website] (c 2004), European Food Safety Authority, Brussels. http://www.efsa.eu.int/science/sc_commitee/sc_documents/616_en.html [updated September 21, 2004, accessed November 14, 2005], available from: http://www.efsa.eu.int/science/sc_commitee/sc_documents/616_en.html
11. Larsen L.L., and Berry J.A. The regulation of dietary supplements. J Am Acad Nurse Pract 15 (2003) 410-414
12. Roemheld-Hamm B., and Chasteberry. Am Fam Physician 72 (2005) 821-824
13. McKenna D.J., Jones K., Humphrey S., and Hughes K. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther Health Med 7 (2001) 93-100
14. Albertazzi P., Steel S.A., Clifford E., and Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric 5 (2002) 374-382
15. Mahady G.B., Parrot J., Lee C., Yun G.S., and Dan A. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 10 (2003) 65-72
16. Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol 43 (2000) 162-183
17. Goldstein M.S., and Glik D. Use of and satisfaction with homeopathy in a patient population. Altern Ther Health Med 4 (1998) 60-65
18. Schimpff S.C. Complementary medicine. Curr Opin Oncol 9 (1997) 327-331
19. Lee M.M., Lin S.S., Wrensch M.R., Adler S.R., and Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92 (2000) 42-47
20. Seidl M.M., and Stewart D.E. Alternative treatments for menopausal symptoms. Qualitative study of women's experiences. Can Fam Physician 44 (1998) 1271-1276
21. Landmark Healthcare. The landmark report on public perceptions of alternative care (1997), Landmark Healthcare, Sacramento, CA
22. Geller S.E., Studee L., Chandra G., and Knowledge. Attitudes and behaviors of health care providers for botanical and dietary supplement use for menopausal health. Menopause 12 (2005) 49-55
23. Kligler B. Black cohosh. Am Fam Physician 68 (2003) 114-116
24. In: Upton R. (Ed). Black cohosh rhizome [monograph on the internet] (2002), American Herbal Pharmacopoeia, Santa Cruz, CA. http://www.herbal-ahp.org/documents/mono_contents/black_cohosh.pdf [accessed 2006 July 17]. Available from: http://www.herbal-ahp.org/documents/mono_contents/black_cohosh.pdf
25. Dog T.L., Powell K.L., and Weisman S.M. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10 (2003) 299-313
26. Einer-Jensen N., Zhao J., Andersen K.P., and Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25 (1996) 149-153
27. Freudenstein J., Dasenbrock C., and Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res 62 (2002) 3448-3452
28. Seidlova-Wuttke D., Jarry H., Becker T., Christoffel V., and Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 44 Suppl. 1 (2003) S39-S50
29. Liu Z.P., Yu B., Huo J.S., Lu C.Q., and Chen J.S. Estrogenic effects of Cimicifuga racemosa (black cohosh) in mice and on estrogen receptors in MCF-7 cells. J Med Food 4 (2001) 171-178
30. Burdette J.E., Liu J., Chen S.N., et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 51 (2003) 5661-5670
31. Mahady G.B. Is black cohosh estrogenic?. Nutr Rev 61 (2003) 183-186
32. Black cohosh. In: Blumenthal M. (Ed). The ABC clinical guide to herbs (2002), American Botanical Council, Austin, TX 13-22
33. Zava D.T., Dollbaum C.M., and Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 217 (1998) 369-378
34. Liu J., Burdette J.E., Xu H., et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49 (2001) 2472-2479
35. Zierau O., Bodinet C., Kolba S., Wulf M., and Vollmer G. Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol 80 (2002) 125-130
36. Bodinet C., and Freudenstein J. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat 76 (2002) 1-10
37. Osmers R., Friede M., Liske E., Schnitker J., Freudenstein J., and Henneicke-von Zepelin H.H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105 (2005) 1074-1083
38. Frei-Kleiner S., Schaffner W., Rahlfs V.W., Bodmer C., and Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51 (2005) 397-404
39. Wuttke W., Seidlova-Wuttke D., and Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 Suppl. 1 (2003) S67-S77
40. Wuttke W., Raus K., and Gorkow C. Efficacy and tolerability of the black cohosh (Actea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study. Maturitas 55 Supp. 1 (2006) 83-91
41. Duker E.M., Kopanski L., Jarry H., and Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 57 (1991) 420-424
42. Nappi R.E., Malavasi B., Brundu B., and Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 20 (2005) 30-35
43. Liske E., Hanggi W., Henneicke-von Zepelin H.H., Boblitz N., Wustenberg P., and Rahlfs V.W. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 11 (2002) 163-174
44. Lehmann-Willenbrock E., and Riedel H.H. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa [German]. Zentralbl Gynakol 110 (1988) 611-618
45. Raus K, Brucker C, Gorkow C, Wuttke W. First time proof of endometrial safety of the special Black cohosh extract (Actea racemosa or Cimicifuga racemosa extract) CR BNO 1055. Menopause, 2006 [Epub ahead of print].
46. Vermes G., Banhidy F., and Acs N. The effects of remifemin on subjective symptoms of menopause. Adv Ther 22 (2005) 148-154
47. Pockaj B.A., Loprinzi C.L., Sloan J.A., et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 22 (2004) 515-521
48. Hernandez Munoz G., and Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 44 Suppl. 1 (2003) S59-S65
49. Jacobson J.S., Troxel A.B., Evans J., et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19 (2001) 2739-2745
50. Pepping J. Black cohosh, Cimicifuga racemosa. Am J Health Syst Pharm 56 (1999) 1400-1402
51. Lontos S., Jones R.M., Angus P.W., and Gow P.J. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 179 (2003) 390-391
52. Whiting P.W., Clouston A., and Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 177 (2002) 440-443
53. Cohen S.M., O'Connor A.M., Hart J., Merel N.H., and Te H.S. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11 (2004) 575-577
54. NIH. Workshop on the safety of black cohosh in clinical studies. National Center for Complementary and Alternative Medicine; NIH Office of Dietary Supplements: Washington, DC (2004)
55. Thomsen M., and Schmidt M. Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated. J Altern Complement Med 9 (2003) 337-340
56. Thomsen M., Vitetta L., Sali A., and Schmidt M. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 180 (2004) 598-599 [author reply 99-600]
57. Davis V.L., Jayo M.J., Hardy M.L., et al. Effects of black cohosh on mammary tumor development and progression in MMTV-neu transgenic mice. Am Assoc Cancer Res Proc 44 (2003) R910
58. Kupfersztain C., Rotem C., Fagot R., and Kaplan B. The immediate effect of natural plant extract. Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clin Exp Obstet Gynecol 30 (2003) 203-206
59. Hirata J.D., Swiersz L.M., Zell B., Small R., and Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 68 (1997) 981-986
60. Lucks B.C., Sorensen J., and Veal L. Vitex agnus-castus essential oil and menopausal balance: a self-care survey. Complement Ther Nurs Midwifery 8 (2002) 148-154
61. Komesaroff P.A., Black C.V., Cable V., and Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 4 (2001) 144-150
62. Chenoy R., Hussain S., Tayob Y., O'Brien P.M., Moss M.Y., and Morse P.F. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308 (1994) 501-503
63. Elsabagh S., Hartley D.E., and File S.E. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. J Psychopharmacol 19 (2005) 173-181
64. Hartley D.E., Heinze L., Elsabagh S., and File S.E. Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba. Pharmacol Biochem Behav 75 (2003) 711-720
65. Hartley D.E., Elsabagh S., and File S.E. Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr Neurosci 7 (2004) 325-333
66. Tode T., Kikuchi Y., Hirata J., Kita T., Nakata H., and Nagata I. Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet 67 (1999) 169-174
67. Wiklund I.K., Mattsson L.A., Lindgren R., and Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 19 (1999) 89-99
68. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490. Fortschr Med 109 (1991) 119-122
69. Grube B., Walper A., and Wheatley D. St. John's wort extract: efficacy for menopausal symptoms of psychological origin. Adv Ther 16 (1999) 177-186
70. de Klerk G.J., Nieuwenhuis M.G., and Beutler J.J. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ 314 (1997) 731-732
71. Radix angelicae sinensis. WHO monographs on selected medicinal plants (2001), WHO, Geneva, Switzerland
72. Blumenthal M. Herbal medicine: expanded Commision E monographs (2003), Integrative Medicine Communications, Newton, MA
73. Brown D. The use of Vitex agnus castus for hyperprolactinemia. Q Rev Nat Med (1997, Spring) 19-21
74. McMillan T.L., and Mark S. Complementary and alternative medicine and physical activity for menopausal symptoms. JAMWA 59 (2004) 270-277
75. Kleijnen J., and Knipschild P. Ginkgo biloba. Lancet 340 (1992) 1136-1139
76. Rudofsky G. Effect of Ginkgo biloba extract in arterial occlusive disease. Randomized placebo controlled crossover study [German]. Fortschr Med 105 (1987) 397-400
77. Bauer U. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforschung 34 (1984) 716-720
78. Birks J., Grimley E.V., and Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane database syst rev (2002) [CD003120]
79. Fugh-Berman A. Herb-drug interactions. Lancet 355 (2000) 134-138
80. Amato P., Christophe S., and Mellon P.L. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9 (2002) 145-150
81. In: Blumenthal M. (Ed). The ABC clinical guide to herbs (2003), American Botanical Council, Austin, TX
82. Motherwort [website]. Science Views.com; c2003-04 [accessed December 01, 2005]. Available from: http://scienceviews.com/plants/motherwort.html.
83. Balderer G., and Borbely A.A. Effect of valerian on human sleep. Psychopharmacology (Berl) 87 (1985) 406-409
84. Leathwood P.D., and Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med (1985) 144-148
85. Leathwood P.D., Chauffard F., Heck E., and Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17 (1982) 65-71
86. Valeriana officinalis. Alternative medicine review, vol. 9 (2004) p. 438-40
87. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., and Melchart D. St John's wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ 313 (1996) 253-258
88. Linde K., Berner M., Egger M., and Mulrow C. St John's wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 186 (2005) 99-107
89. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv Ther 15 (1998) 45-53
90. Zhou S., Chan E., Pan S.Q., Huang M., and Lee E.J. Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol 18 (2004) 262-276